SCHEMBL7335540

SCHEMBL7335540

COc1cccc(-c2ccc(C)c(CN3CCN(C(c4ccccc4)c4ccccc4)CC3)c2)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.48
▸ USP2 O75604 2/20 0.48
▸ NPSR1 Q6W5P4 2/20 0.48
▸ ALDH1A1 P00352 1/20 0.48
▸ OPRK1 P41145 3/20 0.47
▸ OPRM1 P35372 2/20 0.47
▸ OPRD1 P41143 1/20 0.47
▸ OPRL1 P41146 1/20 0.47
▸ SIGMAR1 Q99720 3/20 0.46
▸ MAPT P10636 1/20 0.46
▸ CYP3A4 P08684 3/20 0.45
▸ CYP2C19 P33261 2/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ HTR7 P34969 1/20 0.45
▸ DRD4 P21917 3/20 0.45
▸ HTR2B P41595 3/20 0.45
▸ SLC6A3 Q01959 3/20 0.45
▸ ADRA2A P08913 2/20 0.45
▸ ADRA2C P18825 2/20 0.45
▸ SLC6A2 P23975 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8989126 0.91 LMNA (0.48) LMNAUSP2ALDH1A1OPRK1OPRM1
SCHEMBL27463912 0.89 OPRD1 (0.53) LMNAUSP2NPSR1OPRK1OPRM1
SCHEMBL7330964 0.84 CYP3A4 (0.58) LMNAUSP2NPSR1ALDH1A1OPRK1
SCHEMBL7336021 0.82 ACHE (0.60) LMNAUSP2NPSR1OPRK1OPRM1
SCHEMBL8989095 0.79 CYP2D6 (0.48) LMNAUSP2OPRK1OPRM1OPRD1
SCHEMBL7335379 0.79 DRD4 (0.60) LMNAUSP2ALDH1A1OPRK1OPRM1
Hydrochloric Acid SCHEMBL7326590 0.78 CYP2D6 (0.47) LMNAUSP2OPRK1OPRM1OPRD1
SCHEMBL7331242 0.77 ALDH1A1 (0.63) LMNAUSP2NPSR1ALDH1A1OPRK1
SCHEMBL8963551 0.76 DRD2 (0.51) LMNAUSP2NPSR1ALDH1A1OPRK1
Hydrochloric Acid SCHEMBL7356889 0.76 APOBEC3A (0.52) LMNAALDH1A1OPRK1OPRM1OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5545645-A Heterocyclic derivatives in the treatment of ischaemia and related diseases SYNTEX PHARMACEUTICALS, LIMITED (GB) 1996-08-13 — — US disclosed
EP-0693062-A1 HETEROCYCLIC DERIVATIVES IN THE TREATMENT OF ISCHAEMIA AND RELATED DISEASES SYNTEX PHARMACEUTICALS LTD. (GB) 1996-01-24 — — EP disclosed
US-5428037-A Piperazine derivatives; calcium and sodium channel antagonists SYNTEX PHARMACEUTICALS, LTD. (GB) 1995-06-27 — — US disclosed
WO-1994024116-A1 HETEROCYCLIC DERIVATIVES IN THE TREATMENT OF ISCHAEMIA AND RELATED DISEASES SYNTEX PHARMACEUTICALS LIMITED (GB) 1994-10-27 — — WO disclosed
Send feedback